Background
==========

Ozone (O~3~), an ubiquitous, oxidizing, and highly toxic air pollutant is generated photo-chemically from nitric oxides and hydrocarbons. O~3~is associated with an immediate impairment of lung function and contributes to increased morbidity in patients with asthma and chronic obstructive pulmonary disease (COPD) \[[@B1],[@B2]\]. Even in healthy subjects, short-term exposure to O~3~increases levels of the vascular adhesion molecules P-selectin and ICAM-1 in airway lavages and bronchial tissue and induces influx of neutrophils and mast cells \[[@B3]\]. In mouse, it has been shown that the quality and time course of the cellular response vary considerably between different inbred strains. Some strains like 129/J and DBA/2J respond with an early peak of polymorphonuclear cells six hours after exposure, whereas C57BL/6J mice reach the peak of inflammation 24 hrs after exposure. Additionally, A/J and C3H/HeJ mice respond with only minimal cellular influx \[[@B4]\]. The O~3~-induced acute pathological changes are characterized by an influx of neutrophils and airway hyperresponsiveness (AHR). Long-term or chronic exposure to O~3~, however, attenuates inflammatory responses, a phenomenon referred to as adaptation \[[@B5]\]. The early adaptive response (within 18 hrs after O~3~exposure) is largely IL-6 dependent but the late adaptive response (several days after exposure) involves mobilization of pulmonary antioxidants and leads to hypertrophy and metaplasia of epithelial cells in the upper as well as in the lower respiratory tract \[[@B5]-[@B8]\]. The mechanisms influencing the severity of the O3-induced pulmonary reaction and the molecules involved in the modulation of this response are yet to be fully determined.

Surfactant protein-D (SP-D), a pattern-recognition molecule of the pulmonary innate immune system, enhances the phagocytosis and clearance of various inhaled pathogens, allergens, and apoptotic cells in the lung and serves as a potent immuno-modulator \[[@B9]-[@B11]\]. SP-D possesses anti- as well as pro-inflammatory functions depending on binding specificities and orientation against cell surface receptors \[[@B12]\]. SP-D also inhibits T-cell activation and allergic inflammatory events and it may function as a local regulator of a T-helper type 2 (Th2) inflammation \[[@B13]-[@B15]\]. The expression of SP-D is regulated developmentally but SP-D levels increase from baseline constitutive expression under a variety of lung inflammatory conditions \[[@B16],[@B17]\]. We have previously shown that SP-D production induced during allergic inflammation is mediated by the Th2 cytokine IL-4 \[[@B13],[@B18]\]. However, little is known regarding the role and regulation of SP-D in non-antigen-related inflammatory changes of the lung. Recently, Casey and colleagues proposed an anti-inflammatory role of SP-D in a mouse model of bleomycin-induced lung injury \[[@B19]\]. Since different mouse strains not only vary in their airway responses to O~3~but also express different levels of SP-D, we hypothesized that there is a causal relationship between these two characteristics. To test our hypothesis and to better characterize the role SP-D may play in O~3~-induced inflammation, we used mice with reportedly different SP-D levels \[[@B13]\] and mice lacking SP-D \[[@B20]\] We found that mice expressing high levels of SP-D had significantly less severe inflammatory responses as compared to mice with low or no SP-D. Additionally, the O~3~-inducible cytokine IL-6 selectively induced the expression of SP-D *in vitro*.

Methods
=======

Animals
-------

All experimental animals used in this study were housed under pathogen-free conditions. Experiments were performed between 8 and 12 weeks of age. Animals received water and food *ad libitum*. The protocols were approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania and GlaxoSmithKline.

Modes of O~3~exposure
---------------------

To evaluate the effects of O~3~exposure in mouse strains with different SP-D levels, we used Balb/c and C57BL/6 mice and exposed them to 3.0 ppm O~3~for a 2 hrs period. BAL SP-D levels, cellular and cytokine content were evaluated 6 hrs later. To define the kinetics of the O~3~-induced inflammation and SP-D production in more detail, C57BL/6 mice (Jackson Laboratory, Bar Harbor, ME) were exposed to 3.0 ppm O~3~or air for a 2 hrs period and studied 2, 6, 12, 24, 48, and 72 hrs later. Finally, to study the effects of a complete lack of SP-D, SP-D knockout mice \[[@B20]\] were exposed to either 3.0 ppm O~3~for 2 hrs or to 0.5 ppm O~3~for 24 hrs. BAL was performed 12 hrs (2 hrs exposure) and 24 and 48 hrs (24 hrs exposure) later. In all experiments age- and strain-matched controls were exposed to room air concurrently. The levels and exposure times were based on a previous pilot study (unpublished) and were chosen to accommodate all three different mouse strains and to allow us to study and compare the temporal inflammatory changes. After exposure, groups of mice (n = 6) were euthanized and BAL was performed.

Bronchoalveolar lavage (BAL)
----------------------------

### Differential cell count

BAL was performed as previously described \[[@B13]\]. Briefly, mice were euthanized with an i.p. injection of a mixture of ketamine and xylazine (100 mg/kg and 20 mg/kg respectively). A tracheotomy was performed and the trachea was canulated with a 20 gauge blunt end needle. Lavage was carried out once with 0.7 ml and twice with 1 ml sterile PBS. The recovered BAL from three lavages was pooled. BAL was centrifuged at 4°C for 10 min. at 400 *g*and the pellet was resuspended in 1 ml of PBS. Total cell counts were determined from an aliquot of the cell suspension. Differential cell counts were done on cytocentrifuge preparations (Cytospin 3; Thermo Shandon, Pittsburgh, PA) stained with Kwik™Diff (Thermo Shadon, Pittsburgh, PA), and 200 -- 500 cells were counted from each individual.

### Cytokine assays, SP-D Western blots and ELISA

Cytokine and chemokine levels in the cell-free BAL were determined as part of a Luminex^®^100™ assay System (Luminex Corporation, Austin, TX) and Endogen^®^SearchLight™ Mouse Cytokine and Chemokine arrays (Pierce Biotechnology Inc., IL), respectively, and was performed according to the manufacturer\'s instructions.

Total protein from cell free supernatant of the BAL fluids was assessed using the Bradford Assay (BioRad, CA). Western blots for SP-D levels in cell-free BAL fluid were performed as previously described \[[@B18]\]. Briefly, 4 μg of total protein were loaded and run on an SDS-PAGE and transferred onto nitrocellulose membranes. Membranes were incubated with a rabbit polyclonal anti-SP-D antibody (Chemicon Int., Temecula, CA), followed by incubation with horseradish peroxidase conjugated goat anti-rabbit IgG (Bio-Rad, CA). Specific binding was visualized by enhanced chemiluminescence with ECL Kit (Amersham, IL). The intensity of the signals was quantified with GelPro Analyzer 4.0 (Media Cybernetics Inc., NJ) software. The band density values obtained from individuals were expressed as percentage of the band intensities of treated animal to non-treated, naïve samples. To be able to compare different mouse strains the mean baseline levels in each strain were assigned the value 100 % (± SEM).

SP-D protein recovered from BAL was quantified by ELISA using an in-house rabbit polyclonal anti-SP-D antibody \[[@B18]\]. Aliquots of the BAL samples neat or diluted with blocking buffer (1 % BSA, 2 % normal goat serum, 0.5 % Tween-20 in Dulbecco\'s Phosphate-buffered saline) were applied to 96-well Nunc-Immuno Max iSorp plates (Nalgene Nunc International, Denmark). Each assay plate included a standard of purified SP-D peptide (0.31 to 40 ng/ml) \[[@B18]\]. Polyclonal anti-SP-D antiserum was applied as a primary antibody (1:10,000) and horseradish peroxidase conjugated goat anti-rabbit IgG (1:1,000) was used as the secondary antibody. Colorimetric detection was performed using ABC reagent (Vectastain ABC kit, Vector Laboratories, Burlingame, CA) according to the manufacturer\'s instructions. Color intensity was measured at 405 nm using an automated microplate reader (Bio-Rad, Hercules, CA) and analyzed with Bio-Rad Microplate manager software. Overlapping serial dilution curves of the SP-D peptides and the purified SP-D protein showed a semi-logarithmic relationship between OD and concentration. ELISA for SP-A was performed as published previously \[[@B13]\].

### Alveolar type II cell culture

Lung alveolar type II cells were isolated from neonatal Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA) as previously described \[[@B3],[@B18]\]. Our method yields approximately 60% of type II cells (positive for the lamellar body protein ABCA3). Major contaminating cell types are macrophages and fibroblasts. The viability of type II cells in our culture system is about 85--95 %. Cells were cultured in serum-free Weymouth\'s MB 752/1 medium (Invitrogen, Carlsbad, CA) containing DCI \[Dexamethasone (10 nM), 8-Br-cAMP (100 μM) and Isobutylmethylxantine (100 μM) all from Sigma, St. Luis, MO)\] in the presence or absence of IL-6 (BD Pharmingen, San Diego, CA) for 4 days. Western blots for intra-cellular SP-D were performed as described above.

Data analysis
-------------

Statistical analysis was performed with Prism4 software (GraphPad Inc., San Diego, CA). Multiple comparisons were performed by one-way-ANOVA followed by Barlett\'s test or Post test for linear trend. Student *t*-test was used for two-group comparisons. Data are expressed as mean ± SEM, p \< 0.05 was considered statistically significant.

Results
=======

A relative SP-D deficiency in Balb/c mice was associated with exaggerated inflammatory changes 6 hrs after O~3~exposure
-----------------------------------------------------------------------------------------------------------------------

We have previously reported that SP-D levels in Balb/c and C57BL/6 mice differ under normal conditions as well as upon allergen sensitization and challenge \[[@B13]\]. Since SP-D is a potent immuno-regulator we were interested in evaluating whether these mouse strains would show quantitative differences in their inflammatory response to O~3~. In these experiments BAL SP-D levels in the different moue strains were normalized to 100%, i.e. their mean baseline level. We previously published results of a direct comparison between naïve Balb/c and naïve C57BL/6 mice in which Western blot analysis demonstrated that C57BL/6 mice had approximately twice as much SP-D as Balb/c mice \[[@B13]\]. As shown in Fig. [1A](#F1){ref-type="fig"}, O~3~-exposure caused a significant drop in SP-D levels in Balb/c (but not in C57BL/6) in comparison with air exposed controls (p = 0.0249). Six hours after O~3~exposure, the amount of SP-D recovered from the BAL (and [normalized to the baseline]{.ul}) was significantly lower in Balb/c mice compared with C57BL/6 mice (p = 0.0027).

![**A decrease in BAL SP-D levels was associated with significantly increased inflammation in Balb/c mice 6 hrs after O3 exposure**. Groups of Balb/c (grey bars) and C57BL/6 (black bars) mice were exposed to O~3~or room air for 2 hrs and BAL was performed 6 hrs later. **(A)**Ozone exposed Balb/c mice had significantly reduced SP-D levels as compared to air exposed Balb/c or O~3~exposed C57BL/6 mice. SP-D was detected by Western blot analysis of the cell-free supernatant of the BAL (top panel) and was performed using our in-house rabbit polyclonal anti-SP-D antibody. Two representative samples out of a total of six are shown in each group. SP-D expression was quantified by densitometric analysis. Results are expressed as % of naïve control levels. \* p = 0.0249 *vs*. room air; p = 0.0027 *vs*. C57BL/6. **(B)**Balb/c mice had significantly higher numbers of inflammatory cells in their BAL as compared to C57BL/6 mice. Cells were counted using a Coulter counter and results are expressed as cell number/ml (\*p = 0.0316). **(C):**The BAL total protein content was significantly higher in Balb/c mice compared to C57BL/6 mice. Total protein was measured by Bradford assay in the cell-free supernatant \*p = 0.028. Absolute protein contents were 919,6 (± 51,4) and 3262,3 (± 281.0) in air and O~3~exposed Balb/c mice, respectively, and 772 (± 26.4) and 2110 (± 36.4) in air and O~3~exposed C57BL/6 mice, respectively.**(D-G):**Cytokine expression was studied by Endogen^®^SearchLight™ and Luminex^®^100™ technologies. O~3~induced the release of IL-12p70 (34 pg/ml ± 4 in Balb/c, 18.7 pg/ml ± 1 in C57BL/6), IL-6 (2,393 pg/ml ± 119 in Balb/c, 412 pg/ml ± 68.7 in C57BL/6), IL-10 (110 pg/ml ± 16 in Balb/c, 14.2 pg/ml ± 1.6 in C57BL/6) and KC (1,896 pg/ml ± 224 in Balb/c, 136.8 pg/ml ± 27.7 in C57BL/6). Cytokine and chemokine levels are expressed as % increase from control levels. The O~3~- induced pro-inflammatory cytokine IL-12p70 and KC levels were significantly higher (\*p = 0.0134 and \*p = 0.0001, respectively) whereas the immunosuppressive IL-10 and the immunoregulatory IL-6 levels were significantly lower (\*p \< 0.0001 and \*p \< 0.0001, respectively) in Balb/c mice than in C57BL/6 mice. **(A-G):**Mean ± SEM of n = 6 in each groups.](1465-9921-7-85-1){#F1}

Balb/c mice also had significantly more inflammatory cells (mainly neutrophils, approx. 50 % of total cell counts) compared to C57BL/6 mice (p = 0.0316; Fig. [1B](#F1){ref-type="fig"}). Moreover, Balb/c mice had significantly higher total protein content in their BAL as compared to C57BL/6, indicating more severe lung injury (p = 0.028; Fig. [1C](#F1){ref-type="fig"}). The levels of the pro-inflammatory cytokine IL-12p70 and the neutrohpil chemo-attractant KC were significantly higher in Balb/c as compared to C57BL/6 mice (p = 0.0134 and p = 0.0001, respectively; Fig. [1D--E](#F1){ref-type="fig"}) after O~3~challenge. In contrast, C57BL/6 mice released more IL-10 and IL-6 (p \< 0.0001 and p \< 0.0001, respectively; Fig. [1F--G](#F1){ref-type="fig"}). Absolute cytokine levels are indicated in the figure legend.

Kinetics of SP-D during O~3~-induced inflammatory changes
---------------------------------------------------------

To study the kinetics of SP-D changes in the context of O~3~-induced inflammation we used C57BL/6 mice (the \"SP-D high\" strain) and followed the onset and resolution of the inflammation at 0, 2, 6, 12, 24, 48, and 72 hrs after O~3~exposure. ELISA for SP-D and SP-A recovered from the BAL fluid of O~3~-exposed mice showed significant elevation of SP-D levels with approximately 50 % increase from baseline 12 hrs post-exposure. SP-D continued to increase until the last time point of the experiment (72 hrs) when SP-D levels were about 150 % above control levels (p = 0.0022; Fig. [2A](#F2){ref-type="fig"}). SP-A levels on the other hand did not change significantly. The SP-D ELISA results were verified using Western blot analysis. The two different methods showed a significant positive Spearman correlation r = 0.86 (p = 0.0238). Inflammatory cells were detected 2 hrs after O~3~-exposure, and the numbers were significantly increased compared to naïve animals and peaked around 12 hrs post-exposure (p \< 0.0001; Fig. [2B](#F2){ref-type="fig"}). A slight increase in the numbers of lymphocytes (up to 3 % of total cell counts) was also observed with a time course comparable with that of neutrophilic cells (p = 0.0003; not shown). Eosinophil counts showed a transient peak at 6 hrs, but their number remained less than 1 % of total cell counts at all time points (not significant; not shown). Airway neutrophilia resolved markedly within 72 hrs after O~3~exposure indicating an inverse relationship between the rise of SP-D levels and the decrease of inflammatory cells, including neutrophils and lymphocytes (Fig. [2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}). There was however no statistical correlation between these parameters. The neutrophil influx was preceded by a significant increase in KC levels but there was no significant correlation between this chemokine and neutrophil recruitment. Release of KC into the airways started 2 hrs after O~3~challenge and reached a peak at 6 hrs (p \< 0.0001; not shown). KC levels were back to baseline by 24 hrs. Interestingly, IL-6 was highly induced, with a peak at the 6 hrs time point and a return to baseline levels 48 hrs post-exposure (p \< 0.0001; Fig. [2C](#F2){ref-type="fig"}). Release of the anti-inflammatory cytokine IL-10 was delayed by several hours. IL-10 levels were slightly but significantly increased with highest values between 6--24 hrs after O~3~challenge (p = 0.0007; Fig. [2D](#F2){ref-type="fig"}).

![**Kinetics of O~3~-induced SP-D and inflammatory changes in C57BL/6 mice**. Groups of C57BL/6 mice were exposed to 3 ppm O~3~or room air and studied 0, 2, 6, 12, 24, 48, and 72 hrs later. **(A):**SP-D and SP-A recovered from the BAL were quantified by an in-house ELISA. Results are expressed as % change from naïve controls. SP-D levels gradually increased until the 72 hrs time point (p = 0.0022, ANOVA and post test for linear trend) whereas SP-A levels did not change significantly. **(B)**: The number of neutrophilic granulocytes was assessed by counting total number of BAL cells in the BAL fluid and performing differential cell counting on Kwick™Diff cytospin preparations. Results are expressed as absolute cell number/ml of BAL fluid. Neutrophilic inflammation peaked around 12 hrs post exposure (p \< 0.0001) and largely resolved by 72 hrs after O~3~exposure. **(C-D)**IL-6 and IL-10 levels were assessed as part of a Luminex^®^100™ assay and showed significant increases 2--6 hrs after O~3~exposure (p \< 0.0001) and 6--24 hrs after O~3~exposure (p = 0.0007), respectively. **(A-D):**Mean ± SEM of n = 6 in each groups.](1465-9921-7-85-2){#F2}

SP-D deficient mice have increased cellular inflammation following O~3~exposure
-------------------------------------------------------------------------------

To further evaluate the anti-inflammatory role of SP-D in the O~3~-induced immune response we used SP-D deficient mice and compared them with age- and sex-matched C57BL/6 wild-type controls. SP-D deficient mice showed a baseline inflammation that was further increased after O~3~exposure. The O~3~-induced cellular response was significantly higher in SP-D -/- mice compared to wt C57BL/6 mice 12hrs after acute O~3~exposure (p = 0.0106; Fig. [3A](#F3){ref-type="fig"}). In addition, when mice were exposed to O~3~for 24 hrs (0.5ppm O~3~), a sub-acute exposure, this finding was confirmed, since SP-D -/- mice had increased numbers of inflammatory cells both 24 and 48 hrs after cessation of O~3~exposure (Fig. [3B](#F3){ref-type="fig"}, p = 0.0082). Unlike after acute O~3~exposure (Fig. [2B](#F2){ref-type="fig"}), neither the wild type nor the SP-D-/- mice showed signs of resolution of cellular infiltration at the 48 hrs time point after sub-acute exposure. On the contrary, inflammatory cell numbers were further increased (Fig. [3B](#F3){ref-type="fig"}).

![**SP-D deficient mice have increased airway inflammation following O~3~exposure**. (A) SP-D -/- mice and age-matched C57BL/6 controls were exposed to 3 ppm O~3~for 2 hrs or (B) to 0.5 ppm for 24 hrs. Influx of neutrophilic granulocytes was assessed on cytospin preparations stained with Kwick™Diff. In both models cellular inflammation in SP-D -/- mice was significantly higher compared to wt mice (A) Student *t*-test \*p = 0.0106 (B) ANOVA and Barlett\'s test \*p = 0.0082.](1465-9921-7-85-3){#F3}

IL-6 selectively induces the production of SP-D *in vitro*
----------------------------------------------------------

We have shown previously that SP-D induction in allergic inflammation is dependent on IL-4 and IL-13 \[[@B15],[@B18]\]. Although, none of these Th2 type cytokines was induced in the present model of O~3~challenge, the production of SP-D was highly up-regulated. Therefore we tested the possibility that one of the O~3~-inducible cytokines is capable of promoting SP-D expression. Since IL-6 showed the most pronounced changes following O~3~challenge, and since it is a pluripotent immuno-regulatory cytokine, we chose to investigate its effects on SP-D gene expression *in vitro*. As shown in Fig. [4A](#F4){ref-type="fig"}, *in vitro*stimulation of primary rat alveolar type II cells revealed that IL-6 is indeed capable of directly up-regulating SP-D production. The effect of IL-6 was dose dependent (Fig. [4B](#F4){ref-type="fig"}) and selective for SP-D, because SP-A production was not changed (Fig. [4A](#F4){ref-type="fig"}).

![***In vitro*production of SP-D by alveolar type II cells after IL-6 stimulation**. (A) Primary rat alveolar type II cells were cultured in the presence or absence of DCI and IL-6 for up to 4 days and intra-cellular SP-D and SP-A levels were assayed by Western blot analysis. Day 0 SP-D and SP-A signals were obtained from freshly isolated alveolar type II cells. To maintain the SP-D producing phenotype, cells have to be cultured in the presence of DCI (10 nM dexamethason, 100 nM IBMX, 10 nM cAMP) that in turn stimulates SP-D production. IL-6 selectively stimulated the production of SP-D but did not induce up-regulation of SP-A. (B) Increase of SP-D after IL-6 stimulation at day 4 was slightly dose dependent. All levels were compared to non-stimulated alveolar type II cells cultured in DCI containing medium (DCI control).](1465-9921-7-85-4){#F4}

Discussion
==========

Our results confirm the findings of other investigators showing that acute O~3~exposure induces a rapid onset and resolution of airway inflammatory changes characterized by a KC-driven neutrophilic inflammation and moderately increased numbers of lymphocytes, eosinophils and macrophages \[[@B4],[@B6]\]. Altered levels of surfactant protein D have been reported in association with a number of different pathological conditions of the lung \[[@B13],[@B15],[@B18],[@B21]-[@B24]\]. Here we show that O~3~exposure induces a delayed expression of SP-D. Our data also show that the susceptibility to O~3~-induced inflammatory changes varies between different mouse strains and appears to be associated with different levels of SP-D. C57BL/6 mice that express high levels of SP-D also produce high levels of the anti-inflammatory cytokine IL-10 and high levels of IL-6. In contrast, Balb/c mice release significantly more KC and IL-12p70. Elevated levels of SP-D are associated with the resolution of the O~3~-induced inflammation and low levels or lack of SP-D predispose to a severe inflammatory response.

The drop in SP-D levels seen in Balb/c mice 6 hrs after O~3~exposure could be due to a direct damage and/or apoptosis of SP-D producing epithelial cells \[[@B25]\]. It is likely that this acute phenomenon affects stored SP-D only, because *de-novo*mRNA expression occurs only about 6 hrs after allergen challenge or pulmonary infection and increased levels of SP-D protein were only detected at about 12 hrs (Fig. [2A](#F2){ref-type="fig"}) \[[@B13],[@B18],[@B26]\]. Additionally, the size of the extracellular SP-D pool might be important in the protection from O~3~-induced epithelial injury. Although the authors did not specifically investigate the role of SP-D, Li and colleagues demonstrated that endotoxin pre-treatment, which is expected to induce SP-D production, protects against O~3~-induced cell death and pulmonary inflammation \[[@B27],[@B28]\]. This could explain why C57BL/6 mice with their higher levels of SP-D were more protected from the acute effects of O~3~. Although it has been shown previously that different mouse strains vary in their acute O~3~-induced pulmonary response \[[@B4]\], no host factors responsible for the individual susceptibility have been identified. Savov and co-workers identified several chromosomal regions that appeared to be associated with the physiologic and biologic phenotypes \[[@B4]\]. Their *in silico*genome scan indicates that a locus between 30 and 40 megabases (Mb) on mouse chromosome (MMU) 14 contains one or more relevant genes. It is noteworthy, that the gene coding for SP-D is located on MMU 14 in the area of 37.2 Mb. Additionally, two recent reports identified sequence polymorphisms in the human SP-D gene that lead to differences in constitutive serum levels and influence the multimeric assembly and function of SP-D protein \[[@B29],[@B30]\].

Neutrophils play a vital role in the pulmonary host defense. However, due to their release of large amounts of histo-toxic and pro-inflammatory agents, these cells can cause significant tissue damage. Hence, a stringent control of neutrophil priming, recruitment, activation, apoptosis and clearance is crucial to confine tissue damage \[[@B31]\]. Mice genetically deficient in SP-D have chronic inflammation and hyper-activated macrophages further strengthening the important role of SP-D as a local regulator of the innate immune response \[[@B20],[@B32],[@B33]\]. In a recent publication White and colleagues demonstrated that SP-D may either inhibit or enhance neutrophil respiratory burst responses to influenza A virus. Their data also suggest that the effects of SP-D are modulated by the presence of other respiratory innate immune proteins such as SP-A, and on the multimerization state of SP-D \[[@B34]\]. Other studies show that administration of recombinant SP-D enhances the up-take of apoptotic cells and reduces the production of pro-inflammatory cytokines \[[@B35],[@B36]\]. In line with those results, our study shows that levels of KC, the main chemo-attractant for neutrophils, significantly dropped in concert with a significant elevation of SP-D 12 hrs after O~3~exposure in C57BL/6 mice. However, whether or not SP-D has a direct regulatory effect on KC remains to be determined and is the current focus of our studies.

Ozone exposure does not induce the release of classical Th2 type cytokines such IL-4 or IL-13 which have been shown to stimulate the expression of SP-D \[[@B18]\]. However, in our study we show that O~3~induced a significant rise in BAL SP-D suggesting that there are other mechanisms to promote SP-D expression during a non-allergen induced inflammation. Indeed, our *in vitro*studies using rat alveolar type II cells show that IL-6 is capable of inducing SP-D production. In a different model of airway inflammation, elicited by allergic sensitization and challenge, we have previously shown that a rapid release of pro-inflammatory cytokines is followed by a relatively slow, gradual elevation of SP-D protein levels in the airways, with a peak 48 hours after allergen challenge \[[@B15]\]. In accordance to that, SP-D protein levels were still increased at 48 and 72 hrs when IL-6 levels were already back to normal. IL-6 can transduce its signal either via C/EBPβ or via Stat3 activation. The SP-D promoter region harbours binding sites for both of these transcription factors \[[@B37]\]. Whether IL-6-dependent SP-D gene expression is promoted by C/EBPβ or Stat3 or synergistically by both of them remains to be clarified. Interestingly, IL-6 deficient mice have significantly less BAL protein, neutrophils and soluble TNF receptors after exposure to sub-acute levels of O~3~\[[@B38]\]. On the other hand mice over-expressing IL-6 are protected from lung injury caused by chronic hypoxia \[[@B39]\]. These findings point out the pluripotent functions of IL-6 as an anti- as well as a pro-inflammatory cytokine. The reports by Johnston *et al*. and Ward *et al*. also provide indirect support of our findings that IL-6 is important in launching a protective pulmonary response. Our results showed that the neutrophil chemoattractant KC and the immunosuppressive cytokine, IL-10 were also elevated in the BAL fluid after O~3~exposure. While the possibility was raised that these mediators could contribute to the up-regulation of SP-D, we found no evidence that lung epithelial cells would express receptor or show any functional response to exogenous IL-10 or KC \[[@B40]\].

Conclusion
==========

Strain dependent differences in SP-D production are associated with differences in the severity of the inflammation. The importance of SP-D in the protection against the initial O~3~-induced injury and during the resolution of the inflammation is confirmed in SP-D knockout mice, as the absence of SP-D resulted in enhancement of the inflammation in these animals. We propose that IL-6 may contribute to the up-regulation of SP-D expression, which in turn inhibits pro-inflammatory changes and promotes resolution of the inflammation following O~3~exposure.
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